2013Academic Journal of Chinese PLA Medical SchoolRequires access

Serum levels of lipid and apolipoprotein in coronary heart disease patients with metabolic syndrome

Qiang Wu

Open publisher page 0 citations

Abstract

Objective To analyze the serum levels of lipid and apolipoprotein(Apo) in coronary heart disease(CHD) patients with metabolic syndrome(MS).Methods One hundred and nineteen CHD patients,who underwent coronary arteriography in our hospital from May 2011 to October 2012,were divided into CHD with MS group(n=53) and CHD without MS group(n=66).Risk factors for CHD were compared between the two groups.Their serum levels of lipid and Apo were measured.Characteristics of lipid profile in CHD patients with MS were analyzed.Results The serum levels of TG,ApoB,ApoC2and ApoC3were significantly higher whereas that of HDL-C and ApoA1were significantly lower in CHD with MS group than in CHD without MS group(P 0.05- 0.01).No significant difference was found in TC,LDL-C,ApoA2 and ApoE between the two groups(P 0.05).The coronary artery lesion was severer in CHD with MS group than in CHD without MS group(P 0.01).Conclusion CHD patients with MS suffer from multiple lipid metabolic disorders which can aggravate their coronary artery lesions.

About this research paper

What this paper is about

Objective To analyze the serum levels of lipid and apolipoprotein(Apo) in coronary heart disease(CHD) patients with metabolic syndrome(MS).Methods One hundred and nineteen CHD patients,who underwent coronary arteriography in our hospital from May 2011 to October 2012,were divided into CHD with MS group(n=53) and CHD without MS group(n=66).Risk factors for CHD were compared between the two groups.Their serum levels of lipid and Apo were measured.Characteristics of lipid profile in CHD patients with MS were analyzed.Results The serum levels of TG,ApoB,ApoC2and ApoC3were significantly higher whereas that of HDL-C and ApoA1were significantly lower in CHD with MS group than in CHD without MS group(P 0.05- 0.01).No significant difference was found in TC,LDL-C,ApoA2 and ApoE between the two groups(P 0.05).The coronary artery lesion was severer in CHD with MS group than in CHD without MS group(P 0.01).Conclusion CHD patients with MS suffer from multiple lipid metabolic disorders which can aggravate their coronary artery lesions.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To analyze the serum levels of lipid and apolipoprotein(Apo) in coronary heart disease(CHD) patients with metabolic syndrome(MS).Methods One hundred and nineteen CHD patients,who underwent coronary arteriography in our hospital from May 2011 to October 2012,were divided into CHD with MS group(n=53) and CHD without MS group(n=66).Risk factors for CHD were compared between the two groups.Their serum levels of lipid and Apo were measured.Characteristics of lipid profile in CHD patients with MS were analyzed.Results The serum levels of TG,ApoB,ApoC2and ApoC3were significantly higher whereas that of HDL-C and ApoA1were significantly lower in CHD with MS group than in CHD without MS group(P 0.05- 0.01).No significant difference was found in TC,LDL-C,ApoA2 and ApoE between the two groups(P 0.05).The coronary artery lesion was severer in CHD with MS group than in CHD without MS group(P 0.01).Conclusion CHD patients with MS suffer from multiple lipid metabolic disorders which can aggravate their coronary artery lesions.

Key concepts: Medicine, Apolipoprotein B, Metabolic syndrome, Internal medicine, Coronary heart disease, Lipid profile, Coronary artery disease, Cardiology

Related papers

Back to paper searchBrowse research topicsOriginal source
Serum levels of lipid and apolipoprotein in coronary heart disease patients with metabolic syndrome — Research Paper | ScholarLens